BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, Canna S, Schulert G, Deterding R, Xu J, Leung AN, Bouzoubaa L, Abulaban K, Baszis K, Behrens EM, Birmingham J, Casey A, Cidon M, Cron RQ, De A, De Benedetti F, Ferguson I, Fishman MP, Goodman SI, Graham TB, Grom AA, Haines K, Hazen M, Henderson LA, Ho A, Ibarra M, Inman CJ, Jerath R, Khawaja K, Kingsbury DJ, Klein-Gitelman M, Lai K, Lapidus S, Lin C, Lin J, Liptzin DR, Milojevic D, Mombourquette J, Onel K, Ozen S, Perez M, Phillippi K, Prahalad S, Radhakrishna S, Reinhardt A, Riskalla M, Rosenwasser N, Roth J, Schneider R, Schonenberg-Meinema D, Shenoi S, Smith JA, Sönmez HE, Stoll ML, Towe C, Vargas SO, Vehe RK, Young LR, Yang J, Desai T, Balise R, Lu Y, Tian L, Bejerano G, Davis MM, Khatri P, Mellins ED; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis 2019;78:1722-31. [PMID: 31562126 DOI: 10.1136/annrheumdis-2019-216040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Verweyen EL, Pickering A, Grom AA, Schulert GS. Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2021;73:1334-40. [PMID: 33452871 DOI: 10.1002/art.41640] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tomaras S, Goetzke CC, Kallinich T, Feist E. Adult-Onset Still's Disease: Clinical Aspects and Therapeutic Approach. J Clin Med 2021;10:733. [PMID: 33673234 DOI: 10.3390/jcm10040733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Di Cola I, Bruno F, Berardicurti O, Monti R, Conforti A, Di Sibio A, Pavlych V, Masciocchi C, Barile A, Cipriani P, Ruscitti P. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study. Clin Rheumatol 2021. [PMID: 33855668 DOI: 10.1007/s10067-021-05727-2] [Reference Citation Analysis]
4 Gao DK, Salomonis N, Henderlight M, Woods C, Thakkar K, Grom AA, Thornton S, Jordan MB, Wikenheiser-Brokamp KA, Schulert GS. IFN-γ is essential for alveolar macrophage driven pulmonary inflammation in macrophage activation syndrome. JCI Insight 2021:147593. [PMID: 34314387 DOI: 10.1172/jci.insight.147593] [Reference Citation Analysis]
5 Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment. Int J Mol Sci 2020;21:E3377. [PMID: 32397684 DOI: 10.3390/ijms21093377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Gower WA, Vece TJ. Pediatric pulmonology 2019 year in review: rare and diffuse lung disease. Pediatr Pulmonol 2021;56:1324-31. [PMID: 33559960 DOI: 10.1002/ppul.25297] [Reference Citation Analysis]
7 Henderson LA, Hoyt KJ, Lee PY, Rao DA, Jonsson AH, Nguyen JP, Rutherford K, Julé AM, Charbonnier LM, Case S, Chang MH, Cohen EM, Dedeoglu F, Fuhlbrigge RC, Halyabar O, Hazen MM, Janssen E, Kim S, Lo J, Lo MS, Meidan E, Son MBF, Sundel RP, Stoll ML, Nusbaum C, Lederer JA, Chatila TA, Nigrovic PA. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight 2020;5:132508. [PMID: 32213704 DOI: 10.1172/jci.insight.132508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
8 Lopez-rodriguez E, Ochs M. Reply to: Comments on “Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C”. Am J Respir Cell Mol Biol 2020;63:399-402. [DOI: 10.1165/rcmb.2020-0158le] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ruscitti P, Berardicurti O, Di Benedetto P, Cipriani P, Iagnocco A, Shoenfeld Y, Giacomelli R. Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. Front Immunol 2020;11:1130. [PMID: 32574264 DOI: 10.3389/fimmu.2020.01130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
10 Alehashemi S, Goldbach-Mansky R. Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18. Front Immunol 2020;11:1840. [PMID: 32983099 DOI: 10.3389/fimmu.2020.01840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
11 Malengier-Devlies B, Decaesteker T, Dekoster K, Vanstapel A, Ahmadzadeh K, Poosti F, Mitera T, Seldeslachts L, Verbeken E, Wouters C, Vande Velde G, Vanoirbeek J, Matthys P. Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis. Front Immunol 2021;12:642778. [PMID: 33777039 DOI: 10.3389/fimmu.2021.642778] [Reference Citation Analysis]
12 Verweyen EL, Schulert GS. Interfering with Interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA). Rheumatology (Oxford) 2021:keab673. [PMID: 34459891 DOI: 10.1093/rheumatology/keab673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kilinc AA, Arslan A, Yildiz M, Kucur M, Adrovic A, Barut K, Sahin S, Cokugras H, Kasapcopur O. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study. Rheumatol Int 2020;40:1701-6. [DOI: 10.1007/s00296-019-04485-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Montano L, Donato F, Bianco PM, Lettieri G, Guglielmino A, Motta O, Bonapace IM, Piscopo M. Air Pollution and COVID-19: A Possible Dangerous Synergy for Male Fertility. Int J Environ Res Public Health 2021;18:6846. [PMID: 34202243 DOI: 10.3390/ijerph18136846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wan L, Gao Y, Gu J, Chi H, Wang Z, Hu Q, Jia J, Liu T, Li B, Teng J, Liu H, Cheng X, Ye J, Su Y, Yang C, Shi H, Zhang M. Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still's disease. Arthritis Res Ther 2021;23:97. [PMID: 33785060 DOI: 10.1186/s13075-021-02482-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gerges Harb J, Noureldine HA, Chedid G, Eldine MN, Abdallah DA, Chedid NF, Nour-Eldine W. SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review. Pathog Dis 2020;78:ftaa033. [PMID: 32633327 DOI: 10.1093/femspd/ftaa033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
17 Kontzias A, Barkhodari A, Yao Q. Pericarditis in Systemic Rheumatologic Diseases. Curr Cardiol Rep 2020;22:142. [PMID: 32910306 DOI: 10.1007/s11886-020-01415-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Horneff G. 5/w mit Gelenkschmerzen: Vorbereitung auf die Facharztprüfung: Fall 41. Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-021-01389-1] [Reference Citation Analysis]
19 Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, Scarpa R. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev 2020;19:102524. [PMID: 32220633 DOI: 10.1016/j.autrev.2020.102524] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 36.5] [Reference Citation Analysis]
20 Ruscitti P, Bruno F, Berardicurti O, Acanfora C, Pavlych V, Palumbo P, Conforti A, Carubbi F, Di Cola I, Di Benedetto P, Cipriani P, Grassi D, Masciocchi C, Iagnocco A, Barile A, Giacomelli R. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences. Ann Rheum Dis 2020;79:1152-5. [PMID: 32719039 DOI: 10.1136/annrheumdis-2020-218048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
21 Buckley MM, Rabinovich CE. Pulmonary Manifestations of Rheumatic Diseases in Children. Pediatr Clin North Am 2021;68:147-66. [PMID: 33228929 DOI: 10.1016/j.pcl.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Case SM, Nigrovic PA. Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis. Paediatr Drugs 2022. [PMID: 35364780 DOI: 10.1007/s40272-022-00496-0] [Reference Citation Analysis]
23 De Benedetti F, Prencipe G, Bracaglia C, Marasco E, Grom AA. Targeting interferon-γ in hyperinflammation: opportunities and challenges. Nat Rev Rheumatol 2021;17:678-91. [PMID: 34611329 DOI: 10.1038/s41584-021-00694-z] [Reference Citation Analysis]
24 Alunno A, Carubbi F, Rodríguez-Carrio J. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. RMD Open 2020;6:e001295. [PMID: 32423970 DOI: 10.1136/rmdopen-2020-001295] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
25 Song H. Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases. World J Pediatr 2020;16:1-4. [DOI: 10.1007/s12519-020-00340-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum 2021;51:858-74. [PMID: 34175791 DOI: 10.1016/j.semarthrit.2021.06.004] [Reference Citation Analysis]
27 Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 2020;34:101515. [PMID: 32387063 DOI: 10.1016/j.berh.2020.101515] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
28 Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment. Int J Mol Sci 2020;21:E3377. [PMID: 32397684 DOI: 10.3390/ijms21093377] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 17.0] [Reference Citation Analysis]
29 Vitale A, Della Casa F, Lopalco G, Pereira RM, Ruscitti P, Giacomelli R, Ragab G, La Torre F, Bartoloni E, Del Giudice E, Lomater C, Emmi G, Govoni M, Maggio MC, Maier A, Makowska J, Ogunjimi B, Sfikakis PP, Sfriso P, Gaggiano C, Iannone F, Dagostin MA, Di Cola I, Navarini L, Ahmed Mahmoud AA, Cardinale F, Riccucci I, Paroli MP, Marucco EM, Mattioli I, Sota J, Abbruzzese A, Antonelli IPB, Cipriani P, Tufan A, Fabiani C, Ramadan MM, Cattalini M, Kardas RC, Sebastiani GD, Giardini HAM, Hernández-rodríguez J, Mastrorilli V, Więsik-szewczyk E, Frassi M, Caggiano V, Telesca S, Giordano HF, Guadalupi E, Giani T, Renieri A, Colella S, Cataldi G, Gentile M, Fabbiani A, Al-maghlouth IA, Frediani B, Balistreri A, Rigante D, Cantarini L. Development and Implementation of the AIDA International Registry for Patients With Still's Disease. Front Med 2022;9:878797. [DOI: 10.3389/fmed.2022.878797] [Reference Citation Analysis]
30 Mejbri M, Theodoropoulou K, Hofer M, Cimaz R. Interleukin-1 Blockade in Systemic Juvenile Idiopathic Arthritis. Pediatr Drugs 2020;22:251-62. [DOI: 10.1007/s40272-020-00392-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Erkens R, Esteban Y, Towe C, Schulert G, Vastert S. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease. Rheum Dis Clin North Am 2021;47:585-606. [PMID: 34635293 DOI: 10.1016/j.rdc.2021.06.003] [Reference Citation Analysis]
32 Worley E, Li W, Jones JT. Atypical Presentation of Systemic Arthritis in a Toddler with Down Syndrome. Case Rep Pediatr 2021;2021:6567770. [PMID: 34422425 DOI: 10.1155/2021/6567770] [Reference Citation Analysis]
33 Canna SW, Schulert GS, de Jesus A, Pickering A, Brunner H, Gadina M, Levine S, Goldbach-Mansky R, Boutelle J, Sinha R, DeBenedetti F, Grom A; NextGen 2019 Participants. Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019. Pediatr Rheumatol Online J 2020;18:53. [PMID: 32664935 DOI: 10.1186/s12969-020-00444-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hosseinikhah SM, Barani M, Rahdar A, Madry H, Arshad R, Mohammadzadeh V, Cucchiarini M. Nanomaterials for the Diagnosis and Treatment of Inflammatory Arthritis. Int J Mol Sci 2021;22:3092. [PMID: 33803502 DOI: 10.3390/ijms22063092] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Ruscitti P, Berardicurti O, Iacono D, Pantano I, Liakouli V, Caso F, Emmi G, Grembiale RD, Cantatore FP, Atzeni F, Perosa F, Scarpa R, Guggino G, Ciccia F, Barile A, Cipriani P, Giacomelli R. Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients. Arthritis Res Ther 2020;22:151. [PMID: 32571407 DOI: 10.1186/s13075-020-02245-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Morelle G, Castelle M, Pinto G, Breton S, Bendavid M, Boussard C, Mouy R, Bader-Meunier B, Semeraro M, Faye A, Cavazzana M, Neven B, Blanche S, Quartier P, Moshous D. Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2021;19:27. [PMID: 33712044 DOI: 10.1186/s12969-021-00523-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ohmura S, Uehara K, Yamabe T, Tamechika S, Maeda S, Naniwa T. Successful use of short-term add-on tocilizumab for refractory adult-onset still’s disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide. Modern Rheumatology Case Reports 2020;4:202-7. [DOI: 10.1080/24725625.2020.1741073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
38 Joseph D, Tintinger GR, Ker JA, Pannell N. Adverse effects of biologic anti-inflammatory agents on the respiratory system: A review. Afr J Thorac Crit Care Med 2021;27. [PMID: 34430870 DOI: 10.7196/AJTCCM.2021.v27i2.117] [Reference Citation Analysis]
39 Fingerhutová Š, Jančová E, Doležalová P. Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe? Front Pediatr 2022;10:823847. [DOI: 10.3389/fped.2022.823847] [Reference Citation Analysis]
40 Chau AS, Cole BL, Debley JS, Nanda K, Rosen ABI, Bamshad MJ, Nickerson DA, Torgerson TR, Allenspach EJ. Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares. Pediatr Rheumatol Online J 2020;18:80. [PMID: 33066778 DOI: 10.1186/s12969-020-00474-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]